Latest Trials

EudraCT Number: 2004-000798-71 Sponsor Protocol Number: 1 Start Date: 2004-08-11
Sponsor Name: Imperial College London
Full Title: Efficacy of Levetiracetam in Pendular Nystagmus: A Randomized, Double-blind, Placebo-controlled trial with crossover
Medical condition: Pendular Nystagmus from various etiology
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults Gender: Male, Female
Trial protocol: GB (Prematurely Ended)
Trial results: View results
EudraCT Number: 2004-000487-27 Sponsor Protocol Number: 0663-806 Start Date: 2004-08-10
Sponsor Name: Merck Sharp & Dohme (Sweden) AB
Full Title: A Double-Blind, Parallel-Group, 4-week Trial to Assess the Efficacy and Safety of Etoricoxib 60mg and Diclofenac 150mg in Patients with Chronic Low Back Pain
Medical condition: Chronic Low Back Pain
Disease: Version SOC Term Classification Code Term Level
7.0 10008837 LLT
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: SE (Completed) HU (Completed) IT (Completed)
Trial results: View results
EudraCT Number: 2004-000414-39 Sponsor Protocol Number: BUP4203 Start Date: 2004-08-10
Sponsor Name: Mundipharma OY
Full Title: A randomised, double-blind, placebo-controlled, parallel group, multicenter study to evaluate the long-term efficacy and safety of Norspan® versus placebo Norspan in subjects with chronic, moderate...
Medical condition: Chronic, moderate to severe osteoarthritis pain of the hip and/or knee.
Disease: Version SOC Term Classification Code Term Level
5.1 10031161 LLT
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: FI (Completed) SE (Completed)
Trial results: View results
EudraCT Number: 2004-000589-11 Sponsor Protocol Number: F1D-MC-HGKR Start Date: 2004-08-10
Sponsor Name: ELI LILLY and COMPANY
Full Title: Protocol F1D-MC-HGKR. Olanzapine Plus Carbamazepine Versus Carbamazepine Alone in the Treatment of Manic or Mixed Episodes Associated with Bipolar I Disorder
Medical condition: Manic or Mixed Episodes Associated with Bipolar I Disorder
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults Gender: Male, Female
Trial protocol: HU (Completed)
Trial results: View results
EudraCT Number: 2004-000476-13 Sponsor Protocol Number: SP738 Start Date: 2004-08-10
Sponsor Name: Schwarz Biosciences GmbH
Full Title: LONG-TERM OPEN-LABEL EXTENSION TRIAL FOR SUBJECTS COMPLETING THE PHASE 3 TRIAL OF FESOTERODINE (SP583) FOR THE TREATMENT OF OVERACTIVE BLADDER SYNDROME
Medical condition: overactive bladder
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: ES (Completed) IT (Completed)
Trial results: View results
EudraCT Number: 2004-000025-29 Sponsor Protocol Number: CQAB149B2205 Start Date: 2004-08-10
Sponsor Name: Novartis Sweden AB
Full Title: Full title of the trial : A randomized, double-blind, placebo-controlled, parallel group, multi-center, multiple dose (7 days) dose-ranging study, to assess the efficacy and safety of 4 doses of ...
Medical condition: Moderate to severe Chronic Obstructive Pulmonary Disease
Disease: Version SOC Term Classification Code Term Level
10010952
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: SE (Completed) DK (Completed) BE (Completed)
Trial results: View results
EudraCT Number: 2004-001100-12 Sponsor Protocol Number: 1198.022 Start Date: 2004-08-09
Sponsor Name: Boehringer Ingelheim Pharma Ges mbH
Full Title: A multi-centre, double-blind, parallel-group, randomised, placebo-controlled study to investigate the safety and tolerability of 0.25, 0.5 and 1.0 mg NS 2330 orally and once daily during a 14-week ...
Medical condition: Mild to moderate dementia of the Alzheimer's type
Disease: Version SOC Term Classification Code Term Level
5 10001897 High
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: CZ (Completed) HU (Completed) SK (Completed)
Trial results: View results
EudraCT Number: 2004-000039-27 Sponsor Protocol Number: MI-CP110 Start Date: 2004-08-09
Sponsor Name: MedImmune, Inc.
Full Title: A pivotal phase 3 study of MEDI-524 (Numax), an enhanced potency humanized respiratory syncytial virus (RSV) monoclonal antibody, for the prophylaxis of serious RSV disease in high-risk children.
Medical condition: Serious respiratory syncytial virus (RSV) disease
Disease: Version SOC Term Classification Code Term Level
7.0 10061603
Population Age: Preterm newborn infants, Newborns, Infants and toddlers, Under 18 Gender: Male, Female
Trial protocol: SE (Completed) HU (Completed) CZ (Completed) DK (Completed) IS (Completed) AT (Completed) IT (Completed) GB (Completed)
Trial results: (No results available)
EudraCT Number: 2004-000866-11 Sponsor Protocol Number: 7164-L-01 Start Date: 2004-08-06
Sponsor Name: ZAMBON GROUP
Full Title: A multicenter, randomized, parallel group, controlled, double-blind study to evaluate efficacy and safety of pholcodine as antitussive agent vs dextrometorphan in non-productive cough
Medical condition: Symptomatic treatment of non productive cough
Disease: Version SOC Term Classification Code Term Level
6.1 10011224 PT
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: IT (Completed)
Trial results: View results
EudraCT Number: 2004-000882-36 Sponsor Protocol Number: PAD20001 Start Date: 2004-08-05
Sponsor Name: GlaxoSmithKine Research & Development Limited
Full Title: A multi-centre, two-staged with interim analysis, parallel, randomised, double blind, placebo-controlled, dose ranging study of the safety, tolerability, and effects on plasma high-density lipoprot...
Medical condition: Treatment of dyslipidaemia
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: SE (Completed) FI (Completed) LT (Completed) DK (Completed)
Trial results: View results

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe